SEC Form D · Amendment · filed April 12, 2013
Callidus Biopharma, Inc
Offering
$5.0M
Sold
$4.6M
Exemption
—
Industry
Pharmaceuticals
Location
DOYLESTOWN, PA
Type
—
People & firms on this filing (2)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗